Page last updated: 2024-08-16

rolipram and luminol

rolipram has been researched along with luminol in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boichot, E; Escofier, N; Germain, N; Lagente, V; Martins, MA; Silva, PM1
Al-Ayadhi, LY; Al-Tuwajri, AS1

Other Studies

2 other study(ies) available for rolipram and luminol

ArticleYear
Effects of interleukin-10 and modulators of cyclic AMP formation on endotoxin-induced inflammation in rat lung.
    Fundamental & clinical pharmacology, 1999, Volume: 13, Issue:1

    Topics: Administration, Inhalation; Adrenergic beta-Agonists; Albuterol; Animals; Bronchoalveolar Lavage Fluid; Bucladesine; Cell Count; Cyclic AMP; Dose-Response Relationship, Drug; Endotoxins; Free Radical Scavengers; Inflammation; Interleukin-10; Lipopolysaccharides; Luminescent Measurements; Luminol; Lung; Male; Neutrophils; Phosphodiesterase Inhibitors; Pyrrolidinones; Rats; Rats, Wistar; Rolipram; Salmeterol Xinafoate; Superoxide Dismutase; Theophylline; Tumor Necrosis Factor-alpha; Zymosan

1999
The synergistic effect of adenosine A2A receptors agonist, type IV phosphodiestease inhibitor and ATP-sensitive K channels activation on free radicals production and aggregation of human polymorphoneuclear leukocytes.
    Pharmacological research, 2004, Volume: 50, Issue:2

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenosine; Adenosine A2 Receptor Agonists; Cell Aggregation; Cell Survival; Cromakalim; Cyclic Nucleotide Phosphodiesterases, Type 4; Dose-Response Relationship, Drug; Drug Synergism; Free Radicals; Humans; Luminescent Measurements; Luminol; Neutrophils; Phenethylamines; Phosphodiesterase Inhibitors; Potassium Channels, Inwardly Rectifying; Reactive Oxygen Species; Receptor, Adenosine A2A; Respiratory Burst; Rolipram; Tetradecanoylphorbol Acetate

2004
chemdatabank.com